SlideShare a Scribd company logo
1 of 39
RESEARCH PROCESS IN PHCA -PHARMACOECONOMICS ,[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Preview
PHARMACOECONOMICS RESEARCH ,[object Object],[object Object],[object Object],[object Object],[object Object]
VALUE Health Outcome Cost
USE OF PHARMACOECONOMIC RESEARCH ,[object Object],[object Object],[object Object],[object Object],[object Object]
NEEDS TO MONITOR VALUE OF PHARMACEUTICALS ,[object Object],[object Object],[object Object],[object Object]
TYPES OF PHARMACOECONOMIC EVALUATION ,[object Object],[object Object],[object Object],[object Object],[object Object]
COMPARING PHARMACOECONOMIC METHODOLOGIES ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
STEPS FOR CONDUCTING A PHARMACOECONOMIC EVALUATION ,[object Object],[object Object],[object Object],[object Object]
DEFINE THE PROBLEM AND STATE THE OBJECTIVE ,[object Object],[object Object],[object Object],[object Object],[object Object]
PERSPECTIVE ,[object Object],[object Object],[object Object],[object Object]
PERSPECTIVE ,[object Object]
IDENTIFYING ALTERNATIVE INTERVENTIONS ,[object Object]
IDENTIFYING ALTERNATIVE INTERVENTIONS ,[object Object]
IDENTIFY AND MEASURE OUTCOMES OF EACH ALTERNATIVE INTERVENTION ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
OUTCOMES ,[object Object],[object Object],[object Object]
IDENTIFYING,MEASUREMENT AND VALUATION OF COSTS ,[object Object],[object Object]
IDENTIFYING RELEVANT COSTS ,[object Object],[object Object]
COSTS ,[object Object],[object Object],[object Object]
Costs can be described in many ways ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
MEASURING COSTS ,[object Object],[object Object]
VALUING COSTS ,[object Object]
SENSITIVITY ANALYSIS ,[object Object],[object Object]
DISCOUNTING ,[object Object],[object Object]
COST-MINIMIZATION ANALYSIS (CMA) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
COST-MINIMIZATION ANALYSIS (CMA) ,[object Object]
Cost-Minimization Analysis of Once-Weekly Versus Thrice-Weekly Epoetin Alfa for Chemotherapy-Related Anemia ,[object Object],[object Object],[object Object]
Cost-Minimization Analysis of Once-Weekly Versus Thrice-Weekly Epoetin Alfa for Chemotherapy-Related Anemia ,[object Object],[object Object],[object Object],[object Object]
Cost-Minimization Analysis of Once-Weekly Versus Thrice-Weekly Epoetin Alfa for Chemotherapy-Related Anemia ,[object Object],[object Object],[object Object],[object Object],[object Object]
COST-EFFECTIVENESS ANALYSIS (CEA) ,[object Object],[object Object],[object Object]
COST-EFFECTIVENESS ANALYSIS (CEA) ,[object Object],$43/ADDITIONAL SUCCESSFUL CASE TREATED $122/SUCCESFUL CASE 0.78 $95 C $260/ADDITIONAL SUCCESSFUL CASE TREATED $187/SUCCESFUL CASE 0.80 $150 B $155/SUCCESFUL CASE 0.55 $85 A ICER Average cost effectiveness ratio Outcome (Success rate) Average cost per patient Alternative
COST-BENEFIT ANALYSIS (CBA) ,[object Object],[object Object],[object Object],[object Object]
COST-BENEFIT ANALYSIS (CBA) ,[object Object],[object Object],[object Object]
COST-UTILITY ANALYSIS (CUA) ,[object Object],[object Object],[object Object],[object Object],[object Object]
COST-UTILITY ANALYSIS (CUA) ,[object Object],[object Object],[object Object],[object Object],[object Object]
COST-CONSEQUENCE ANALYSIS (CCA) ,[object Object],- - - - Cases successfully treated - - - - Clinical - - -- - Quality of life (QALY) - - - - Consequences - - - - Productivity (lost days/episode) - - - - Caregiver time - - - - Indirect - - - - Transportation - - - - Direct Non Medical - - - - Hospitalizations - - - - Physician costs - - - - Drug therapy Costs Units  Costs Units  Direct Medical Drug B Drug A Cost (per Patient)
COST-CONSEQUENCE ANALYSIS (CCA) ,[object Object],[object Object],[object Object]
JOURNALS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
REFERENCES ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

More Related Content

What's hot

DRUG USE MEASURES.pptx
DRUG USE MEASURES.pptxDRUG USE MEASURES.pptx
DRUG USE MEASURES.pptxAmeena Kadar
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
PharmacoeconomicsAsma Ashraf
 
INTRODUCTION TO PHARMACOECONOMICS.pptx
INTRODUCTION TO PHARMACOECONOMICS.pptxINTRODUCTION TO PHARMACOECONOMICS.pptx
INTRODUCTION TO PHARMACOECONOMICS.pptxAmeena Kadar
 
Pharmacoeconomics pptx
Pharmacoeconomics pptxPharmacoeconomics pptx
Pharmacoeconomics pptxVishwasATL
 
Measurement of outcomes in epidemiology
Measurement of outcomes in epidemiologyMeasurement of outcomes in epidemiology
Measurement of outcomes in epidemiologyDr. Ankit Gaur
 
Drug Utilization review
Drug Utilization review Drug Utilization review
Drug Utilization review Pooja Panjwani
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
PharmacoeconomicsZainab&Sons
 
Concept of risk in pharmacoepidemiology Presentation
Concept of risk in pharmacoepidemiology PresentationConcept of risk in pharmacoepidemiology Presentation
Concept of risk in pharmacoepidemiology PresentationMdshams244
 
Drug utilisation evaluation
Drug utilisation evaluation Drug utilisation evaluation
Drug utilisation evaluation Irene Vadakkan
 
Measurement of outcomes in pharacoepidemiology
Measurement of outcomes in pharacoepidemiologyMeasurement of outcomes in pharacoepidemiology
Measurement of outcomes in pharacoepidemiologyDr. Ashish singh parihar
 
Pharmacoeconomics Cost utility analysis
Pharmacoeconomics Cost utility analysisPharmacoeconomics Cost utility analysis
Pharmacoeconomics Cost utility analysisMohammed Mohammed
 
Cost utility analysis
Cost utility analysisCost utility analysis
Cost utility analysisARUNAYESUDAS
 
introduction to Pharmacoepidemiology
introduction to Pharmacoepidemiology introduction to Pharmacoepidemiology
introduction to Pharmacoepidemiology aiswarya thomas
 

What's hot (20)

Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Adverse drug reaction causality assessment
Adverse drug reaction causality assessmentAdverse drug reaction causality assessment
Adverse drug reaction causality assessment
 
DRUG USE MEASURES.pptx
DRUG USE MEASURES.pptxDRUG USE MEASURES.pptx
DRUG USE MEASURES.pptx
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
INTRODUCTION TO PHARMACOECONOMICS.pptx
INTRODUCTION TO PHARMACOECONOMICS.pptxINTRODUCTION TO PHARMACOECONOMICS.pptx
INTRODUCTION TO PHARMACOECONOMICS.pptx
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Hospital Pharmaco-epidemiology
Hospital Pharmaco-epidemiology Hospital Pharmaco-epidemiology
Hospital Pharmaco-epidemiology
 
Pharmacoeconomics pptx
Pharmacoeconomics pptxPharmacoeconomics pptx
Pharmacoeconomics pptx
 
Measurement of outcomes in epidemiology
Measurement of outcomes in epidemiologyMeasurement of outcomes in epidemiology
Measurement of outcomes in epidemiology
 
Drug Utilization review
Drug Utilization review Drug Utilization review
Drug Utilization review
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Concept of risk in pharmacoepidemiology Presentation
Concept of risk in pharmacoepidemiology PresentationConcept of risk in pharmacoepidemiology Presentation
Concept of risk in pharmacoepidemiology Presentation
 
Drug utilisation evaluation
Drug utilisation evaluation Drug utilisation evaluation
Drug utilisation evaluation
 
Measurement of outcomes in pharacoepidemiology
Measurement of outcomes in pharacoepidemiologyMeasurement of outcomes in pharacoepidemiology
Measurement of outcomes in pharacoepidemiology
 
Pharmacoeconomics Cost utility analysis
Pharmacoeconomics Cost utility analysisPharmacoeconomics Cost utility analysis
Pharmacoeconomics Cost utility analysis
 
Cost utility analysis
Cost utility analysisCost utility analysis
Cost utility analysis
 
introduction to Pharmacoepidemiology
introduction to Pharmacoepidemiology introduction to Pharmacoepidemiology
introduction to Pharmacoepidemiology
 

Similar to Pharmacoeconomics1

Pharmacoeconomics.ppt
Pharmacoeconomics.pptPharmacoeconomics.ppt
Pharmacoeconomics.pptPabitra Thapa
 
Pharmacoeconomics1
Pharmacoeconomics1Pharmacoeconomics1
Pharmacoeconomics1jinender16
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
PharmacoeconomicsIjeh Cyril
 
Pharmacoeconomics ppt.
Pharmacoeconomics ppt.Pharmacoeconomics ppt.
Pharmacoeconomics ppt.shahvijita
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
PharmacoeconomicsAhmad Ali
 
Intro to pharmacoeconomics
Intro to pharmacoeconomicsIntro to pharmacoeconomics
Intro to pharmacoeconomicssamthamby79
 
Seminar pharmacoeconomics
Seminar pharmacoeconomicsSeminar pharmacoeconomics
Seminar pharmacoeconomicsSameerKhasbage
 
Economicevaluation 08.Pptx
Economicevaluation 08.PptxEconomicevaluation 08.Pptx
Economicevaluation 08.Pptxrlh4
 
Outcomes, health economics and pharmacoeconomics
Outcomes, health economics and  pharmacoeconomicsOutcomes, health economics and  pharmacoeconomics
Outcomes, health economics and pharmacoeconomicsDureshahwar khan
 
lect_3_4_schwartzman_economic_analyses_tb_course_2015.ppt
lect_3_4_schwartzman_economic_analyses_tb_course_2015.pptlect_3_4_schwartzman_economic_analyses_tb_course_2015.ppt
lect_3_4_schwartzman_economic_analyses_tb_course_2015.pptDhanang Nugraha
 
pharmacoeconomic_models.pdf
pharmacoeconomic_models.pdfpharmacoeconomic_models.pdf
pharmacoeconomic_models.pdfKRIMSExamination
 
TOPIC-5-Pharmacoeconomics (1).pptx
TOPIC-5-Pharmacoeconomics (1).pptxTOPIC-5-Pharmacoeconomics (1).pptx
TOPIC-5-Pharmacoeconomics (1).pptxMohamedAdelSarhan1
 

Similar to Pharmacoeconomics1 (20)

Pharmaeconomic
Pharmaeconomic Pharmaeconomic
Pharmaeconomic
 
Pharmacoeconomics ii
Pharmacoeconomics iiPharmacoeconomics ii
Pharmacoeconomics ii
 
Pharmacoeconomics.ppt
Pharmacoeconomics.pptPharmacoeconomics.ppt
Pharmacoeconomics.ppt
 
Pharmacoeconomics1
Pharmacoeconomics1Pharmacoeconomics1
Pharmacoeconomics1
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Pharmaconomics
PharmaconomicsPharmaconomics
Pharmaconomics
 
Pharmaconomics
PharmaconomicsPharmaconomics
Pharmaconomics
 
Pharmacoeconomics seminar
Pharmacoeconomics seminarPharmacoeconomics seminar
Pharmacoeconomics seminar
 
Pharmacoeconomics ppt.
Pharmacoeconomics ppt.Pharmacoeconomics ppt.
Pharmacoeconomics ppt.
 
Pharmaeconomic
Pharmaeconomic Pharmaeconomic
Pharmaeconomic
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Intro to pharmacoeconomics
Intro to pharmacoeconomicsIntro to pharmacoeconomics
Intro to pharmacoeconomics
 
Seminar pharmacoeconomics
Seminar pharmacoeconomicsSeminar pharmacoeconomics
Seminar pharmacoeconomics
 
Economicevaluation 08.Pptx
Economicevaluation 08.PptxEconomicevaluation 08.Pptx
Economicevaluation 08.Pptx
 
Outcomes, health economics and pharmacoeconomics
Outcomes, health economics and  pharmacoeconomicsOutcomes, health economics and  pharmacoeconomics
Outcomes, health economics and pharmacoeconomics
 
Pharmaeconomics
Pharmaeconomics Pharmaeconomics
Pharmaeconomics
 
lect_3_4_schwartzman_economic_analyses_tb_course_2015.ppt
lect_3_4_schwartzman_economic_analyses_tb_course_2015.pptlect_3_4_schwartzman_economic_analyses_tb_course_2015.ppt
lect_3_4_schwartzman_economic_analyses_tb_course_2015.ppt
 
pharmacoeconomic_models.pdf
pharmacoeconomic_models.pdfpharmacoeconomic_models.pdf
pharmacoeconomic_models.pdf
 
TOPIC-5-Pharmacoeconomics (1).pptx
TOPIC-5-Pharmacoeconomics (1).pptxTOPIC-5-Pharmacoeconomics (1).pptx
TOPIC-5-Pharmacoeconomics (1).pptx
 

More from jinender16

Seminar Jinender
Seminar  JinenderSeminar  Jinender
Seminar Jinenderjinender16
 
Patient Attitude Towards Gifts To Physicians
Patient Attitude Towards Gifts To PhysiciansPatient Attitude Towards Gifts To Physicians
Patient Attitude Towards Gifts To Physiciansjinender16
 
Pseudoephedrine
PseudoephedrinePseudoephedrine
Pseudoephedrinejinender16
 
Direct To Consumer Advertising Of Prescription Drugs Pharmaceutical Industry
Direct To Consumer Advertising Of Prescription Drugs Pharmaceutical IndustryDirect To Consumer Advertising Of Prescription Drugs Pharmaceutical Industry
Direct To Consumer Advertising Of Prescription Drugs Pharmaceutical Industryjinender16
 
Poster Jinender
Poster JinenderPoster Jinender
Poster Jinenderjinender16
 

More from jinender16 (9)

ISPOR
ISPORISPOR
ISPOR
 
Poster
PosterPoster
Poster
 
Seminar Jinender
Seminar  JinenderSeminar  Jinender
Seminar Jinender
 
APha Poster
APha PosterAPha Poster
APha Poster
 
Patient Attitude Towards Gifts To Physicians
Patient Attitude Towards Gifts To PhysiciansPatient Attitude Towards Gifts To Physicians
Patient Attitude Towards Gifts To Physicians
 
Singapore
SingaporeSingapore
Singapore
 
Pseudoephedrine
PseudoephedrinePseudoephedrine
Pseudoephedrine
 
Direct To Consumer Advertising Of Prescription Drugs Pharmaceutical Industry
Direct To Consumer Advertising Of Prescription Drugs Pharmaceutical IndustryDirect To Consumer Advertising Of Prescription Drugs Pharmaceutical Industry
Direct To Consumer Advertising Of Prescription Drugs Pharmaceutical Industry
 
Poster Jinender
Poster JinenderPoster Jinender
Poster Jinender
 

Recently uploaded

Annual General Meeting Presentation Slides
Annual General Meeting Presentation SlidesAnnual General Meeting Presentation Slides
Annual General Meeting Presentation SlidesKeppelCorporation
 
FULL ENJOY Call girls in Paharganj Delhi | 8377087607
FULL ENJOY Call girls in Paharganj Delhi | 8377087607FULL ENJOY Call girls in Paharganj Delhi | 8377087607
FULL ENJOY Call girls in Paharganj Delhi | 8377087607dollysharma2066
 
Fordham -How effective decision-making is within the IT department - Analysis...
Fordham -How effective decision-making is within the IT department - Analysis...Fordham -How effective decision-making is within the IT department - Analysis...
Fordham -How effective decision-making is within the IT department - Analysis...Peter Ward
 
Market Sizes Sample Report - 2024 Edition
Market Sizes Sample Report - 2024 EditionMarket Sizes Sample Report - 2024 Edition
Market Sizes Sample Report - 2024 EditionMintel Group
 
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607dollysharma2066
 
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCRashishs7044
 
Cybersecurity Awareness Training Presentation v2024.03
Cybersecurity Awareness Training Presentation v2024.03Cybersecurity Awareness Training Presentation v2024.03
Cybersecurity Awareness Training Presentation v2024.03DallasHaselhorst
 
Flow Your Strategy at Flight Levels Day 2024
Flow Your Strategy at Flight Levels Day 2024Flow Your Strategy at Flight Levels Day 2024
Flow Your Strategy at Flight Levels Day 2024Kirill Klimov
 
Investment in The Coconut Industry by Nancy Cheruiyot
Investment in The Coconut Industry by Nancy CheruiyotInvestment in The Coconut Industry by Nancy Cheruiyot
Investment in The Coconut Industry by Nancy Cheruiyotictsugar
 
Darshan Hiranandani [News About Next CEO].pdf
Darshan Hiranandani [News About Next CEO].pdfDarshan Hiranandani [News About Next CEO].pdf
Darshan Hiranandani [News About Next CEO].pdfShashank Mehta
 
8447779800, Low rate Call girls in Tughlakabad Delhi NCR
8447779800, Low rate Call girls in Tughlakabad Delhi NCR8447779800, Low rate Call girls in Tughlakabad Delhi NCR
8447779800, Low rate Call girls in Tughlakabad Delhi NCRashishs7044
 
Entrepreneurship lessons in Philippines
Entrepreneurship lessons in  PhilippinesEntrepreneurship lessons in  Philippines
Entrepreneurship lessons in PhilippinesDavidSamuel525586
 
Guide Complete Set of Residential Architectural Drawings PDF
Guide Complete Set of Residential Architectural Drawings PDFGuide Complete Set of Residential Architectural Drawings PDF
Guide Complete Set of Residential Architectural Drawings PDFChandresh Chudasama
 
Innovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdfInnovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdfrichard876048
 
Memorándum de Entendimiento (MoU) entre Codelco y SQM
Memorándum de Entendimiento (MoU) entre Codelco y SQMMemorándum de Entendimiento (MoU) entre Codelco y SQM
Memorándum de Entendimiento (MoU) entre Codelco y SQMVoces Mineras
 
Call Us 📲8800102216📞 Call Girls In DLF City Gurgaon
Call Us 📲8800102216📞 Call Girls In DLF City GurgaonCall Us 📲8800102216📞 Call Girls In DLF City Gurgaon
Call Us 📲8800102216📞 Call Girls In DLF City Gurgaoncallgirls2057
 
Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...Seta Wicaksana
 
Unlocking the Future: Explore Web 3.0 Workshop to Start Earning Today!
Unlocking the Future: Explore Web 3.0 Workshop to Start Earning Today!Unlocking the Future: Explore Web 3.0 Workshop to Start Earning Today!
Unlocking the Future: Explore Web 3.0 Workshop to Start Earning Today!Doge Mining Website
 

Recently uploaded (20)

Annual General Meeting Presentation Slides
Annual General Meeting Presentation SlidesAnnual General Meeting Presentation Slides
Annual General Meeting Presentation Slides
 
Call Us ➥9319373153▻Call Girls In North Goa
Call Us ➥9319373153▻Call Girls In North GoaCall Us ➥9319373153▻Call Girls In North Goa
Call Us ➥9319373153▻Call Girls In North Goa
 
FULL ENJOY Call girls in Paharganj Delhi | 8377087607
FULL ENJOY Call girls in Paharganj Delhi | 8377087607FULL ENJOY Call girls in Paharganj Delhi | 8377087607
FULL ENJOY Call girls in Paharganj Delhi | 8377087607
 
Fordham -How effective decision-making is within the IT department - Analysis...
Fordham -How effective decision-making is within the IT department - Analysis...Fordham -How effective decision-making is within the IT department - Analysis...
Fordham -How effective decision-making is within the IT department - Analysis...
 
Market Sizes Sample Report - 2024 Edition
Market Sizes Sample Report - 2024 EditionMarket Sizes Sample Report - 2024 Edition
Market Sizes Sample Report - 2024 Edition
 
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
(Best) ENJOY Call Girls in Faridabad Ex | 8377087607
 
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
 
Cybersecurity Awareness Training Presentation v2024.03
Cybersecurity Awareness Training Presentation v2024.03Cybersecurity Awareness Training Presentation v2024.03
Cybersecurity Awareness Training Presentation v2024.03
 
Flow Your Strategy at Flight Levels Day 2024
Flow Your Strategy at Flight Levels Day 2024Flow Your Strategy at Flight Levels Day 2024
Flow Your Strategy at Flight Levels Day 2024
 
Investment in The Coconut Industry by Nancy Cheruiyot
Investment in The Coconut Industry by Nancy CheruiyotInvestment in The Coconut Industry by Nancy Cheruiyot
Investment in The Coconut Industry by Nancy Cheruiyot
 
Darshan Hiranandani [News About Next CEO].pdf
Darshan Hiranandani [News About Next CEO].pdfDarshan Hiranandani [News About Next CEO].pdf
Darshan Hiranandani [News About Next CEO].pdf
 
8447779800, Low rate Call girls in Tughlakabad Delhi NCR
8447779800, Low rate Call girls in Tughlakabad Delhi NCR8447779800, Low rate Call girls in Tughlakabad Delhi NCR
8447779800, Low rate Call girls in Tughlakabad Delhi NCR
 
Entrepreneurship lessons in Philippines
Entrepreneurship lessons in  PhilippinesEntrepreneurship lessons in  Philippines
Entrepreneurship lessons in Philippines
 
Guide Complete Set of Residential Architectural Drawings PDF
Guide Complete Set of Residential Architectural Drawings PDFGuide Complete Set of Residential Architectural Drawings PDF
Guide Complete Set of Residential Architectural Drawings PDF
 
Innovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdfInnovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdf
 
Memorándum de Entendimiento (MoU) entre Codelco y SQM
Memorándum de Entendimiento (MoU) entre Codelco y SQMMemorándum de Entendimiento (MoU) entre Codelco y SQM
Memorándum de Entendimiento (MoU) entre Codelco y SQM
 
Corporate Profile 47Billion Information Technology
Corporate Profile 47Billion Information TechnologyCorporate Profile 47Billion Information Technology
Corporate Profile 47Billion Information Technology
 
Call Us 📲8800102216📞 Call Girls In DLF City Gurgaon
Call Us 📲8800102216📞 Call Girls In DLF City GurgaonCall Us 📲8800102216📞 Call Girls In DLF City Gurgaon
Call Us 📲8800102216📞 Call Girls In DLF City Gurgaon
 
Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...
 
Unlocking the Future: Explore Web 3.0 Workshop to Start Earning Today!
Unlocking the Future: Explore Web 3.0 Workshop to Start Earning Today!Unlocking the Future: Explore Web 3.0 Workshop to Start Earning Today!
Unlocking the Future: Explore Web 3.0 Workshop to Start Earning Today!
 

Pharmacoeconomics1

  • 1.
  • 2.
  • 3.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.
  • 31.
  • 32.
  • 33.
  • 34.
  • 35.
  • 36.
  • 37.
  • 38.
  • 39.